What are the major opportunities in the Visceral Pain market? What are the strategies for the Visceral Pain market?

For detailed insights on the major opportunities and strategies in the Visceral Pain market, Read More

How does the Visceral Pain market relate to the overall economy and other similar markets?

For detailed insights on Visceral Pain's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Visceral Pain market growth? SWOT analysis of the Visceral Pain market.

For detailed insights on the key dynamics influencing the Visceral Pain market growth and SWOT analysis of the Visceral Pain industry, Read More

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Visceral Pain Global Market Report 2025

Name: Visceral Pain Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Class (Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes), By Indications (Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications), By End Users (Hospitals, Homecare, Specialty Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Visceral Pain Market Overview

• Visceral Pain market size has reached to $13.84 billion in 2024

• Expected to grow to $18.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%

• Growth Driver: Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion

• Market Trend: Innovative NHE3 Inhibitor Advances Visceral Pain Treatment

• North America was the largest region in 2024.

What Is Covered Under Visceral Pain Market?

Visceral pain refers to the pain that originates from the internal organs, such as the stomach, bladder, uterus, or rectum. Visceral pain can be caused by various factors, including inflammation, menstrual cramps, swelling and stretching of the organs, blockage, decreased blood flow, and tumors, especially when concentrated in the pelvis or abdomen. It is commonly associated with additional symptoms such as nausea, perspiration, or an accelerated heartbeat.

The main types of visceral pain drug class are calcium channel blockers, nonsteroidal anti-inflammatories (NSAID), and others. Calcium channel blockers (CCBs) refer to a class of medications that primarily affect the movement of calcium ions into the cells of the heart and blood vessels. The various indications include interstitial cystitis, Crohn’s, Irritable Bowel, chronic prostatitis, and others. These are used by various end-users such as hospitals, homecare, specialty clinics, and others.

Visceral Pain Market Size and growth rate 2025 to 2029: Graph

What Is The Visceral Pain Market Size 2025 And Growth Rate?

What Is The Visceral Pain Market Growth Forecast?

The visceral pain market size is expected to see strong growth in the next few years. It will grow to $18.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to technological innovations in pain management, growing demand for non-invasive treatment options, emerging markets and untapped opportunities, personalized medicine approaches, integration of digital health solutions. Major trends in the forecast period include shift towards multimodal pain management, increasing emphasis on alternative therapies, rise of targeted therapies for specific pain types, growing role of telemedicine in pain management, integration of artificial intelligence in pain assessment.

The forecast of 5.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pain management by inflating prices of neuromodulation devices and targeted analgesic infusion pumps developed in Ireland and Belgium, resulting in prolonged patient suffering and higher chronic pain clinic costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Visceral Pain Market Segmented?

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs

3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

What Is Driving The Visceral Pain Market? Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion

The rising demand for analgesics is expected to fuel the growth of the visceral pain market going forward. Analgesics refer to medications that alleviate pain by diminishing or blocking the perception of pain signals in the brain. Analgesics help manage visceral pain by targeting the nervous system and modulating pain signals originating from internal organs. For instance, in April 2024, according to the New England Journal of Medicinepublished in the New England Journal of Medicine, a UK-based weekly medical journal, over 53,600 clinicians were prescribing buprenorphine by December 2023. This represents an increase of 11,500 prescribers compared to December 2022. Therefore, the rising demand for analgesics is driving the growth of the visceral pain industry.

Who Are The Major Players In The Global Visceral Pain Market?

Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

What Are The Key Trends Of The Global Visceral Pain Market? Innovative NHE3 Inhibitor Advances Visceral Pain Treatment

Major companies operating in the visceral pain market are developing innovative products, such as NHE3 Inhibitor, to provide reliable services to customers. NHE3 inhibitors are a class of medicines that work by inhibiting the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. For instance, in April 2022, Ardelyx, a US-based biopharmaceutical company, launched an NHE3 Inhibitor drug, IBSRELA. IBSRELA represents a pioneering treatment for adults with irritable bowel syndrome with constipation (IBS-C), and IT works by inhibiting the Sodium-Hydrogen Exchanger 3 (NHE3) in the small intestine and colon. It has been shown to reduce abdominal pain by decreasing visceral hypersensitivity and intestinal permeability in animal studies.

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Visceral Pain Market? Marksans Pharma Acquires Teva’s India Facility To Double Production Capacity

In April 2023, Marksans Pharma, an India-based pharmaceutical company, acquired the India manufacturing facility of Teva Pharmaceuticals for an undisclosed amount. As a result of the acquisition, Marksans gains a 47,597-square-meter facility, enabling IT to double its production capacity in India from 8 billion units annually. This added capacity will support the production of tablets, hard and soft gel capsules, ointments, liquids, and creams. Teva Pharmaceuticals is an Israel-based provider of treatments for visceral pain.

What Is The Regional Outlook For The Global Visceral Pain Market?

North America was the largest region in the visceral pain market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Visceral Pain Market?

The visceral pain market consists of sales of opioids, anticonvulsants, gabapentin, and pregabalin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Visceral Pain Industry?

The visceral pain market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the visceral pain industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Visceral Pain Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$14.82 billion
Revenue Forecast In 2034	$18.58 billion
Growth Rate	CAGR of 5.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes 2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications 3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines 2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs 3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Visceral Pain Market Characteristics

3. Visceral Pain Market Trends And Strategies

4. Visceral Pain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Visceral Pain Growth Analysis And Strategic Analysis Framework

5.1. Global Visceral Pain PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Visceral Pain Market Growth Rate Analysis

5.4. Global Visceral Pain Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Visceral Pain Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Visceral Pain Total Addressable Market (TAM)

6. Visceral Pain Market Segmentation

6.1. Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Calcium Channel Blockers

Nonsteroidal Anti-Inflammatory (NSAID)

Other Drug Classes

6.2. Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Interstitial Cystitis

Crohn’s

Irritable Bowel

Chronic Prostatitis

Other Indications

6.3. Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End Users

6.4. Global Visceral Pain Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dihydropyridines

Non-Dihydropyridines

6.5. Global Visceral Pain Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAID), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Selective COX-2 Inhibitors

Non-Selective NSAIDs

6.6. Global Visceral Pain Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Opioids

Tricyclic Antidepressants (TCAs)

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

7. Visceral Pain Market Regional And Country Analysis

7.1. Global Visceral Pain Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Visceral Pain Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Visceral Pain Market

8.1. Asia-Pacific Visceral Pain Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Visceral Pain Market

9.1. China Visceral Pain Market Overview

9.2. China Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Visceral Pain Market

10.1. India Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Visceral Pain Market

11.1. Japan Visceral Pain Market Overview

11.2. Japan Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Visceral Pain Market

12.1. Australia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Visceral Pain Market

13.1. Indonesia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Visceral Pain Market

14.1. South Korea Visceral Pain Market Overview

14.2. South Korea Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Visceral Pain Market

15.1. Western Europe Visceral Pain Market Overview

15.2. Western Europe Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Visceral Pain Market

16.1. UK Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Visceral Pain Market

17.1. Germany Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Visceral Pain Market

18.1. France Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Visceral Pain Market

19.1. Italy Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Visceral Pain Market

20.1. Spain Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Visceral Pain Market

21.1. Eastern Europe Visceral Pain Market Overview

21.2. Eastern Europe Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Visceral Pain Market

22.1. Russia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Visceral Pain Market

23.1. North America Visceral Pain Market Overview

23.2. North America Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Visceral Pain Market

24.1. USA Visceral Pain Market Overview

24.2. USA Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Visceral Pain Market

25.1. Canada Visceral Pain Market Overview

25.2. Canada Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Visceral Pain Market

26.1. South America Visceral Pain Market Overview

26.2. South America Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Visceral Pain Market

27.1. Brazil Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Visceral Pain Market

28.1. Middle East Visceral Pain Market Overview

28.2. Middle East Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Visceral Pain Market

29.1. Africa Visceral Pain Market Overview

29.2. Africa Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Visceral Pain Market Competitive Landscape And Company Profiles

30.1. Visceral Pain Market Competitive Landscape

30.2. Visceral Pain Market Company Profiles

30.2.1. Walgreens Boots Alliance Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Visceral Pain Market Other Major And Innovative Companies

31.1. AbbVie Inc.

31.2. Novartis AG

31.3. Sanofi SA

31.4. Bristol-Myers Squibb Company

31.5. AstraZeneca PLC

31.6. GlaxoSmithKline PLC

31.7. Takeda Pharmaceutical Company Limited

31.8. Eli Lilly and Company

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Mylan N.V.

31.11. Bausch Health Companies Inc.

31.12. Sun Pharmaceutical Industries Ltd.

31.13. Perrigo Company PLC

31.14. Dr. Reddy's Laboratories Ltd.

31.15. Endo International PLC

32. Global Visceral Pain Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Visceral Pain Market

34. Recent Developments In The Visceral Pain Market

35. Visceral Pain Market High Potential Countries, Segments and Strategies

35.1 Visceral Pain Market In 2029 - Countries Offering Most New Opportunities

35.2 Visceral Pain Market In 2029 - Segments Offering Most New Opportunities

35.3 Visceral Pain Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Visceral Pain Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Visceral Pain Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAID), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Visceral Pain Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Visceral Pain Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Visceral Pain Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Walgreens Boots Alliance Inc. Financial Performance

Table 78: Pfizer Inc. Financial Performance

Table 79: Johnson & Johnson Services Inc. Financial Performance

Table 80: F. Hoffmann-La Roche Ltd. Financial Performance

Table 81: Merck & Co. Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Visceral Pain Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Visceral Pain Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAID), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Visceral Pain Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Visceral Pain Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Visceral Pain Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Walgreens Boots Alliance Inc. Financial Performance

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Johnson & Johnson Services Inc. Financial Performance

Figure 80: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 81: Merck & Co. Inc. Financial Performance

Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Ostomy Devices Global Market Report 2025 – By Product (Bags, Accessories), By System Type (One-Piece System, Two-Piece System), By Surgery Type (Colostomy, Urostomy, Ileostomy), By End Users (Ambulatory Surgical Centers,...

View Report

Artificial Turf Global Market Report 2025 – By Material Type (Polyethylene, Polypropylene, Nylon, Other Materials), By Installation (Flooring, Wall Cladding), By Application (Residential, Commercial, Sports) – Impact of ...

View Report

Insurance Analytics Global Market Report 2025 – By Component (Solution, Service), By Deployment Model (On premises, Cloud), By Enterprise Size (Large Enterprises, Small And Medium Enterprises (SMEs)), By Application (Cla...

View Report

Field Programmable Gate Array Global Market Report 2025 – By Technology( EEPROM, Antifuse, SRAM, Flash, Other Technologies ), By Configuration( High-end FPGA, Mid-end FPGA, Low-end FPGA), By Application( Data processing,...

View Report

Shale Gas Processing Equipment Global Market Report 2025 – By Component (Compressors and Pumps, Electrical Machinery, Heat Exchangers, Internal Combustion Engines, Measuring and Controlling Devices, Others Components ), ...

View Report

Industrial Fasteners Global Market Report 2025 – By Type (Externally Threaded, Internally Threaded, Non-Threaded, Aerospace Grade), By Raw Material (Metal, Plastic), By Application (Automotive, Aerospace, Construction, I...

View Report

Headset Global Market Report 2025 – By Type (In-Ear, Over Ear), By Price Band (Below USD 50, USD 51-150, USD 151-350, Over USD 351), By Connectivity (Wired, Wireless), By Application (Smartphone, Personal Computer (PC), ...

View Report

Specialty Consumer Products Global Market Report 2025 – By Price ($50 - $100, $100 - $200, Above $200 ), By Distribution Channel (Specialty Stores, Online Stores ), By End-User (Male, Female, Unisex) – Impact of Tariff a...

View Report

Frequently Asked Questions

What is the definition of the Visceral Pain market?

How will the Visceral Pain market drivers and restraints affect the market dynamics? What forces will shape the Visceral Pain industry going forward?

The market major growth driver - Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Visceral Pain market?

The visceral pain market size has grown strongly in recent years. It will grow from $13.84 billion in 2024 to $14.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to aging population, increased incidence of chronic diseases, advances in medical research, expansion of healthcare infrastructure, rising awareness and diagnosis rates. The visceral pain market size is expected to see strong growth in the next few years. It will grow to " $18.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to technological innovations in pain management, growing demand for non-invasive treatment options, emerging markets and untapped opportunities, personalized medicine approaches, integration of digital health solutions. Major trends in the forecast period include shift towards multimodal pain management, increasing emphasis on alternative therapies, rise of targeted therapies for specific pain types, growing role of telemedicine in pain management, integration of artificial intelligence in pain assessment. For further insights on this market, request a sample here

How is the Visceral Pain market segmented?

The visceral painmarket covered in this report is segmented –
1) By Drug Class: Calcium Channel Blockers; Nonsteroidal Anti-Inflammatory (NSAID); Other Drug Classes
2) By Indications: Interstitial Cystitis; Crohn’s; Irritable Bowel; Chronic Prostatitis; Other Indications
3) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines; Non-Dihydropyridines
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors; Non-Selective NSAIDs
3) By Other Drug Classes: Opioids; Tricyclic Antidepressants (TCAs); Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) For further insights on this market, request a sample here

Which region has the largest share of the Visceral Pain market? What are the other regions covered in the report?

North America was the largest region in the visceral pain market in 2024. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Visceral Pain market?

What are the key trends in the Visceral Pain market?

Major trends in this market include Innovative NHE3 Inhibitor Advances Visceral Pain Treatment. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Visceral Pain Global Market Report 2025

Visceral Pain Market Overview

What Is Covered Under Visceral Pain Market?

What Is The Visceral Pain Market Size 2025 And Growth Rate?

What Is The Visceral Pain Market Growth Forecast?

What’s The Trade War Impact On Healthcare Services Industry?

How Is The Visceral Pain Market Segmented?

What Is Driving The Visceral Pain Market? Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion

Who Are The Major Players In The Global Visceral Pain Market?

What Are The Key Trends Of The Global Visceral Pain Market? Innovative NHE3 Inhibitor Advances Visceral Pain Treatment

What Are Latest Mergers And Acquisitions In The Visceral Pain Market? Marksans Pharma Acquires Teva’s India Facility To Double Production Capacity

What Is The Regional Outlook For The Global Visceral Pain Market?

What Defines the Visceral Pain Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Visceral Pain Industry?

Visceral Pain Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions